Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 5/2008

01-10-2008 | Erratum

Erratum to: Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis

Authors: C Thomas G Appleton, David D McErlain, Vasek Pitelka, Neil Schwartz, Suzanne M Bernier, James L Henry, David W Holdsworth, Frank Beier

Published in: Arthritis Research & Therapy | Issue 5/2008

Login to get access

Excerpt

After publication of our recent article [1], it has been brought to our attention that four panels in Figure 1 have been mislabeled. Images (c) and (e) are femurs, rather than tibias. Similarly, images (d) and (f) should be labelled as tibias. …
Literature
1.
Appleton CTG, McErlain DD, Pitelka V, Schwartz N, Bernier SM, Henry JL, Holdsworth DW, Frank Beier F: Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis. Arthritis Res Ther. 2007, 9: R13-10.1186/ar2120.PubMedCentralCrossRefPubMed
Metadata
Title
Erratum to: Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis
Authors
C Thomas G Appleton
David D McErlain
Vasek Pitelka
Neil Schwartz
Suzanne M Bernier
James L Henry
David W Holdsworth
Frank Beier
Publication date
01-10-2008
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2008
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2513

Other articles of this Issue 5/2008

Arthritis Research & Therapy 5/2008 Go to the issue

Research article

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

Review

Epigenetic modifications in rheumatoid arthritis

Research article

Role of hypoxia-inducible factor 1alpha in the integrity of articular cartilage in murine knee joints

Research article

Menopause, postmenopausal hormone use and serum uric acid levels in US women – The Third National Health and Nutrition Examination Survey

Commentary

Are biologics more effective than classical disease-modifying antirheumatic drugs?

Review

Developments in the scientific understanding of lupus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits